down arrow

Parmax Pharma

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE240T01014
  • NSEID:
  • BSEID: 540359
INR
39.00
-5.7 (-12.75%)
BSENSE

Apr 11, 12:52 PM

BSE+NSE Vol: 18

Click here to access the older version
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

38.5539.02

52 Week

25.0354.00
Valuation
Technical
Day's Volume

CASH

18 (-77.72%) Volume

Shareholding (Dec 2024)

FII

0.00%

Held by 0 FIIs

DII

0.00%

Held by 0 DIIs

Promoter

30.80%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy
Dashboard
1

With HIgh Debt (Debt-Equity Ratio at 5.86 times)- the company has a Weak Long Term Fundamental Strength

  • Poor long term growth as Net Sales has grown by an annual rate of 6.91% and Operating profit at 0% over the last 5 years
  • Company's ability to service its debt is weak with a poor EBIT to Interest (avg) ratio of 0.66
2

Risky - Negative Operating Profits

stock-summaryMojo Parameters
Mojo Parameters
Loading Valuation Snapshot...
Stock DNA
stock-summary
Industry

Pharmaceuticals & Drugs

stock-summary
Market cap

INR 14 Cr (Micro Cap)

stock-summary
P/E

NA (Loss Making)

stock-summary
Industry P/E

33

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

5.86

stock-summary
Return on Equity

-205.00%

stock-summary
Price to Book

16.72

Revenue and Profits (1 Year):
Net Sales:
6 Cr
(Quarterly Results - Dec 2024)
Net Profit:
0 Cr
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
Dividend Yield (0%)
TimePeriod
Price Return
Dividend Return
Total Return
6 Months
3.81%
0%
3.81%
1 Year
27.74%
0%
27.74%
2 Years
26.99%
0%
26.99%
3 Years
-7.14%
0%
-7.14%
4 Years
-1.27%
0%
-1.27%
5 Years
143.75%
0%
143.75%

Parmax Pharma for the last several years.

Risk Adjusted Returns v/s Sensex stock-summary
Returns Beta
Icon
Beta has not been calculated since enough price history is not available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
6.91%
EBIT Growth (5y)
-194.14%
EBIT to Interest (avg)
0.66
Debt to EBITDA (avg)
1.22
Net Debt to Equity (avg)
0
Sales to Capital Employed (avg)
1.75
Tax Ratio
100.00%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
-7.29%
ROE (avg)
0
Valuation key factors
Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
33
Price to Book Value
16.72
EV to EBIT
-14.20
EV to EBITDA
22.58
EV to Capital Employed
3.79
EV to Sales
0.82
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
-84.90%
ROE (Latest)
-205.00%
Tecnicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bearish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bullish
Moving Averages
Bullish (Daily)
KST
Bearish
Bullish
Dow Theory
No Trend
Mildly Bearish
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Dec 2024stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Non Institution

Pledged Promoter Holdings

None

Mutual Funds

Held by 0 Schemes

FIIs

Held by 0 FIIs

Promoter with highest holding

Alkesh Mahasukh Gopani (17.92%)

Highest Public shareholder

Gosalia Meena Alkesh (12.69%)

Individual Investors Holdings

63.12%

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Standalone) - Dec'24 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Dec 2024 is 372.18% vs -75.14% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in quarter ended Dec 2024 is 77.71% vs -200.57% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "6.28",
          "val2": "1.33",
          "chgp": "372.18%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "0.10",
          "val2": "-1.15",
          "chgp": "108.70%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.11",
          "val2": "0.16",
          "chgp": "-31.25%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "-0.39",
          "val2": "-1.75",
          "chgp": "77.71%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "1.59%",
          "val2": "-86.47%",
          "chgp": "88.06%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "half-yearly",
    "btn_text": "All Half Yearly Results",
    "header": "Half Yearly Results Snapshot (Standalone) - Sep'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": " Growth in half year ended Sep 2024 is 212.43% vs 48.24% in Sep 2023",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": " Growth in half year ended Sep 2024 is 92.16% vs -26.24% in Sep 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Sep'24",
        "Sep'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "17.09",
          "val2": "5.47",
          "chgp": "212.43%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "0.71",
          "val2": "-1.42",
          "chgp": "150.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.24",
          "val2": "0.30",
          "chgp": "-20.00%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "-0.20",
          "val2": "-2.55",
          "chgp": "92.16%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "4.15%",
          "val2": "-25.96%",
          "chgp": "30.11%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "nine-monthly",
    "btn_text": "All Nine Monthly Results",
    "header": "Nine Monthly Results Snapshot (Standalone) - Dec'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is 243.68% vs -24.78% in Dec 2023",
        "dir": 1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in nine months ended Dec 2024 is 86.28% vs -1,435.71% in Dec 2023",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Dec'24",
        "Dec'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "23.37",
          "val2": "6.80",
          "chgp": "243.68%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "0.81",
          "val2": "-2.57",
          "chgp": "131.52%",
          "chgp_class": "positive"
        },
        {
          "field": "Interest",
          "val1": "0.35",
          "val2": "0.46",
          "chgp": "-23.91%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "-0.59",
          "val2": "-4.30",
          "chgp": "86.28%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "3.47%",
          "val2": "-37.79%",
          "chgp": "41.26%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Standalone) - Mar'24",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Mar 2024 is -28.34% vs -15.51% in Mar 2023",
        "dir": -1
      },
      {
        "prefix": "Standalone Net Profit ",
        "suffix": "YoY Growth in year ended Mar 2024 is -5,650.00% vs -171.43% in Mar 2023",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Mar'24",
        "Mar'23",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "11.05",
          "val2": "15.42",
          "chgp": "-28.34%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "-3.38",
          "val2": "2.25",
          "chgp": "-250.22%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "0.62",
          "val2": "0.37",
          "chgp": "67.57%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "0.00",
          "val2": "0.00",
          "chgp": "",
          "chgp_class": "neutral"
        },
        {
          "field": "Standalone Net Profit",
          "val1": "-5.75",
          "val2": "-0.10",
          "chgp": "-5,650.00%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "-30.59%",
          "val2": "14.59%",
          "chgp": "-45.18%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]
Quarterly Results Snapshot (Standalone) - Dec'24 - YoYstock-summary
Dec'24
Dec'23
Change(%)
Net Sales
6.28
1.33
372.18%
Operating Profit (PBDIT) excl Other Income
0.10
-1.15
108.70%
Interest
0.11
0.16
-31.25%
Exceptional Items
0.00
0.00
Standalone Net Profit
-0.39
-1.75
77.71%
Operating Profit Margin (Excl OI)
1.59%
-86.47%
88.06%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in quarter ended Dec 2024 is 372.18% vs -75.14% in Dec 2023

Direction Arrows
Standalone Net Profit

YoY Growth in quarter ended Dec 2024 is 77.71% vs -200.57% in Dec 2023

All Quarterly Resultsstock-summary
Half Yearly Results Snapshot (Standalone) - Sep'24stock-summary
Sep'24
Sep'23
Change(%)
Net Sales
17.09
5.47
212.43%
Operating Profit (PBDIT) excl Other Income
0.71
-1.42
150.00%
Interest
0.24
0.30
-20.00%
Exceptional Items
0.00
0.00
Standalone Net Profit
-0.20
-2.55
92.16%
Operating Profit Margin (Excl OI)
4.15%
-25.96%
30.11%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

Growth in half year ended Sep 2024 is 212.43% vs 48.24% in Sep 2023

Direction Arrows
Standalone Net Profit

Growth in half year ended Sep 2024 is 92.16% vs -26.24% in Sep 2023

All Half Yearly Resultsstock-summary
Nine Monthly Results Snapshot (Standalone) - Dec'24stock-summary
Dec'24
Dec'23
Change(%)
Net Sales
23.37
6.80
243.68%
Operating Profit (PBDIT) excl Other Income
0.81
-2.57
131.52%
Interest
0.35
0.46
-23.91%
Exceptional Items
0.00
0.00
Standalone Net Profit
-0.59
-4.30
86.28%
Operating Profit Margin (Excl OI)
3.47%
-37.79%
41.26%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in nine months ended Dec 2024 is 243.68% vs -24.78% in Dec 2023

Direction Arrows
Standalone Net Profit

YoY Growth in nine months ended Dec 2024 is 86.28% vs -1,435.71% in Dec 2023

All Nine Monthly Resultsstock-summary
Annual Results Snapshot (Standalone) - Mar'24stock-summary
Mar'24
Mar'23
Change(%)
Net Sales
11.05
15.42
-28.34%
Operating Profit (PBDIT) excl Other Income
-3.38
2.25
-250.22%
Interest
0.62
0.37
67.57%
Exceptional Items
0.00
0.00
Standalone Net Profit
-5.75
-0.10
-5,650.00%
Operating Profit Margin (Excl OI)
-30.59%
14.59%
-45.18%
Values in Rs Cr.
stock-summary Compare with Peers
Direction Arrows
Net Sales

YoY Growth in year ended Mar 2024 is -28.34% vs -15.51% in Mar 2023

Direction Arrows
Standalone Net Profit

YoY Growth in year ended Mar 2024 is -5,650.00% vs -171.43% in Mar 2023

All Annual Resultsstock-summary
stock-summaryCompany CV
About Parmax Pharma Ltd stock-summary
stock-summary
Parmax Pharma Ltd
Micro Cap
Pharmaceuticals & Drugs
Incorporated in Nov.'94, Parmax Pharma Ltd (PPL) was promoted by Jayantilal S Dhol, Purushottam J Bhalodi and Prabhudas D Hansalpara. The Active Pharmaceutical Ingredients (API) and Contract Manufacturing Operations ( CMO) business are the key pillar of Parmax's pharmaceutical operations. The Promoters were earlier into manufacturing of bulk drugs like Ampicilin, Amoxycillin, Cephalexin, Nalidixic Acid etc.
Company Coordinates stock-summary
Company Details
Plot No 20 Survey No 52, Tal Kotda Sangani Hadamtala Rajkot Gujarat : 360311
stock-summary
Tel: 91-2827-270534/535
stock-summary
http://www.parmaxpharma.com
stock-summary
info@parmaxpharma.com
Registrar Details
Purva Shareregistry (India) Pvt Ltd , Gala No 9, Shiv Shakti, Industrial Estate,Sitaram Mill Comp., J R Boricha Marg, Lower Parel [E], Mumbai
Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."